{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:22:53Z","timestamp":1792596173313,"version":"4.5.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2018,10,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Among his major cardiac electrophysiological contributions, Miles Vaughan Williams (1918\u20132016) provided a classification of antiarrhythmic drugs that remains central to their clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We survey implications of subsequent discoveries concerning sarcolemmal, sarcoplasmic reticular, and cytosolic biomolecules, developing an expanded but pragmatic classification that encompasses approved and potential antiarrhythmic drugs on this centenary of his birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We first consider the range of pharmacological targets, tracking these through to cellular electrophysiological effects. We retain the original Vaughan Williams Classes I through IV but subcategorize these divisions in light of more recent developments, including the existence of Na\n                      <jats:sup>+<\/jats:sup>\n                      current components (for Class I), advances in autonomic (often G protein\u2013mediated) signaling (for Class II), K\n                      <jats:sup>+<\/jats:sup>\n                      channel subspecies (for Class III), and novel molecular targets related to Ca\n                      <jats:sup>2+<\/jats:sup>\n                      homeostasis (for Class IV). We introduce new classes based on additional targets, including channels involved in automaticity, mechanically sensitive ion channels, connexins controlling electrotonic cell coupling, and molecules underlying longer-term signaling processes affecting structural remodeling. Inclusion of this widened range of targets and their physiological sequelae provides a framework for a modernized classification of established antiarrhythmic drugs based on their pharmacological targets. The revised classification allows for the existence of multiple drug targets\/actions and for adverse, sometimes actually proarrhythmic, effects. The new scheme also aids classification of novel drugs under investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We emerge with a modernized classification preserving the simplicity of the original Vaughan Williams framework while aiding our understanding and clinical management of cardiac arrhythmic events and facilitating future developments in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/circulationaha.118.035455","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:00:59Z","timestamp":1540216859000},"page":"1879-1896","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":294,"title":["Modernized Classification of Cardiac Antiarrhythmic Drugs"],"prefix":"10.1161","volume":"138","author":[{"given":"Ming","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Oxford, United Kingdom (M.L., D.A.T.)."},{"name":"Key Laboratory of Medical Electrophysiology of the Ministry of Education and Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China (M.L., L.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University First Hospital, Beijing, China (L.W.)."},{"name":"Key Laboratory of Medical Electrophysiology of the Ministry of Education and Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China (M.L., L.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.","family":"Terrar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Oxford, United Kingdom (M.L., D.A.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.-H.","family":"Huang","sequence":"additional","affiliation":[{"name":"Physiological Laboratory (C.L.-H.H.), University of Cambridge, United Kingdom."},{"name":"Department of Biochemistry (C.L.-H.H.). University of Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","volume-title":"In: Symposium on Cardiac Arrhythmias","author":"Vaughan Williams E","year":"1970","unstructured":"Vaughan Williams, E. Classification of antiarrhythmic drugs. Sandoe, E, Flensted-Jensen, E, Olsen, K, eds. In: Symposium on Cardiac Arrhythmias. Elsinore, Denmark: Astra; 1970: 826pp."},{"key":"e_1_3_4_3_2","first-page":"115","article-title":"Classification of antidysrhythmic drugs.","volume":"1","author":"Vaughan Williams EM","year":"1975","unstructured":"Vaughan Williams, EM. Classification of antidysrhythmic drugs. Pharmacol Ther B. 1975;1:115\u2013138.","journal-title":"Pharmacol Ther B"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/17.5.251"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1984.sp015436"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/B0-7216-0323-8\/50103-2","volume-title":"In: Cardiac Electrophysiology: From Cell to Bedside","author":"Singh B","year":"2004","unstructured":"Singh, B. Beta-blockers and calcium channel blockers as anti-arrhythmic drugs. Zipes, D, Jalife, J, eds. In: Cardiac Electrophysiology: From Cell to Bedside. 4th ed. Philadelphia, PA: Saunders; 2004: 918\u2013931.","edition":"4"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.49.1.1"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_G.32"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e3181bfaddc"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2007"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2005.05.003"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2008"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.01.009"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00080"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"e_1_3_4_17_2","first-page":"899","volume-title":"In: Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Roden D","year":"2006","unstructured":"Roden, D. Antiarrhythmic drugs. Brunton, L, Knollman, B, Hilal-Dandan, R, eds. In: Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics. 11th ed. New York: McGrawHill; 2006:899\u2013932.","edition":"11"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.08.025"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12577"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2016"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2004.04.005"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-009-0761-0"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-017-1959-1"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2008.10.011"},{"key":"e_1_3_4_25_2","unstructured":"National Institue of Health Care Excellence. Arrhythmias. 2014. https:\/\/bnf.nice.org.uk\/treatment-summary\/arrhythmias.html. Accessed September 21 2018."},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000548"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000311"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/B0-7216-0323-8\/50102-0","volume-title":"In: Cardiac Electrophysiology: From Cell to Bedside","author":"Gillis A","year":"2004","unstructured":"Gillis, A. Class I anti-arrhythmic drugs: quinidine, procainamide, disopyramide, lidocaine, mexiletine, flecainide and propafenone. Zipes, D, Jalife, J, eds. In: Cardiac Electrophysiology: From Cell to Bedside. 4th ed. Philadelphia, PA: Saunders; 2004:911\u2013917.","edition":"4"},{"key":"e_1_3_4_30_2","first-page":"815","volume-title":"In: Goodman & Gilman\u2019s The Pharmaceutical Basis of Therapeutics","author":"Sampson K","year":"2011","unstructured":"Sampson, K, Kass, R. Anti-arrhythmic drugs. Brunton, L, Chabner, B, Knollman, B, eds. In: Goodman & Gilman\u2019s The Pharmaceutical Basis of Therapeutics. New York, NY: McGrawHill; 2011:815\u2013848."},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/B0-7216-0323-8\/50102-0","volume-title":"In: Cardiac Electrophysiology: From Cell to Bedside","author":"Gillis A","year":"2004","unstructured":"Gillis, A, Singh, B, Smith, T, Cain, M, Kadish, A, Weiberg, K, Goldberger, J. Pharmacologic therapy. Zipes, D, Jalife, JJ, ed. In: Cardiac Electrophysiology: From Cell to Bedside. 4th ed. Saunders; 2004:911\u2013965.","edition":"4"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13807"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.11.009"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/415198a"},{"key":"e_1_3_4_35_2","first-page":"IV-","article-title":"2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, part 7.3: management of symptomatic bradycardia and tachycardia.","volume":"112","author":"American Heart Association","year":"2005","unstructured":"American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, part 7.3: management of symptomatic bradycardia and tachycardia. Circulation. 2005;112:IV-67\u2013IV-77.","journal-title":"Circulation"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00022.2013"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00076"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2009.01.007"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.4.795"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/B0-7216-0323-8\/50105-6","volume-title":"Cardiac Electrophysiology: In: From Cell to Bedside","author":"DiMarco J","year":"2004","unstructured":"DiMarco, J. Adenosine and digoxin. Zipes, D, Jalife, J, eds. Cardiac Electrophysiology: In: From Cell to Bedside.4th ed. Philadelphia, PA: Saunders; 2004:942\u2013949.","edition":"4"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00005.2004"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00002.2005"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/B0-7216-0323-8\/50104-4","volume-title":"In: Cardiac Electrophysiology: From Cell to Bedside","author":"Smith T","year":"2004","unstructured":"Smith, T, Cain, M. Class III anti-arrhythmic drugs: amiodarone, ibutilide and sotalol. Zipes, D, Jalife, J, eds. In: Cardiac Electrophysiology: From Cell to Bedside. 4th ed. Philadelphia, PA: Saunders; 2004:932\u2013941.","edition":"4"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00008.2016"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00003.2015"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1997.tb01040.x"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2009"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60096-7"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00011.2006"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00016.2013"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2002.2038"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-007-2975-2"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1343"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.70.113006.100455"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131179"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20060377"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2014.12.001"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2010"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.225888"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00082"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.019893"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00014.2006"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00154"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143159.30585.90"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1660"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2006.00388.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300953"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00025.2003"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.208041"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.10.004"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-010-0565-y"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000118464.48959.1C"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2013.04.026"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00019"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.03.022"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00150"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2011.02285.x"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2014.07.003"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.033"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(79)90437-X"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.564008"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004370"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.707877"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.2038"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000092"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.21.2314"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.021165"},{"key":"e_1_3_4_89_2","first-page":"9","article-title":"Development of heart failure in bradycardic sick sinus syndrome.","volume":"2","author":"Alboni P","year":"2001","unstructured":"Alboni, P, Scarf\u00f2, S, Fuc\u00e0, G. Development of heart failure in bradycardic sick sinus syndrome. Ital Heart J. 2001;2:9\u201312.","journal-title":"Ital Heart J"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2015.06.001"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.001693"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.05.005"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007765"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1942"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12505"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2406"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3456"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12288"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.016683"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00347.2012"}],"updated-by":[{"DOI":"10.1161\/cir.0000000000000675","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000}}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.118.035455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:02:51Z","timestamp":1715572971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.118.035455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":99,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,10,23]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.118.035455"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.118.035455","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"2018-10-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}